These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 32815186)

  • 21. EQ-5D-5L norms for the urban Chinese population in China.
    Yang Z; Busschbach J; Liu G; Luo N
    Health Qual Life Outcomes; 2018 Nov; 16(1):210. PubMed ID: 30409137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health problems are more common, but less severe when measured using newer EQ-5D versions.
    Craig BM; Pickard AS; Lubetkin EI
    J Clin Epidemiol; 2014 Jan; 67(1):93-9. PubMed ID: 24075597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-sectional validity of the EQ-5D-Y as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany.
    Eidt-Koch D; Mittendorf T; Greiner W
    BMC Pediatr; 2009 Aug; 9():55. PubMed ID: 19715563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population health status based on the EQ-5D-Y-3L among adolescents in Sweden: Results by sociodemographic factors and self-reported comorbidity.
    Åström M; Persson C; Lindén-Boström M; Rolfson O; Burström K
    Qual Life Res; 2018 Nov; 27(11):2859-2871. PubMed ID: 30196340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health-related quality of life among Indian population: The EQ-5D population norms for India.
    Jyani G; Prinja S; Garg B; Kaur M; Grover S; Sharma A; Goyal A
    J Glob Health; 2023 Feb; 13():04018. PubMed ID: 36799239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
    Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
    J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Norwegian population norms for the EQ-5D-5L: results from a general population survey.
    Garratt AM; Hansen TM; Augestad LA; Rand K; Stavem K
    Qual Life Res; 2022 Feb; 31(2):517-526. PubMed ID: 34272631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EQ-5D-5L Bulgarian population norms.
    Encheva M; Djambazov S; Vekov T; Golicki D
    Eur J Health Econ; 2020 Nov; 21(8):1169-1178. PubMed ID: 32813084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing Measurement Properties of the English EQ-5D-Y 3-Level Version With the 5-Level Version in South Africa.
    Verstraete J; Amien R; Scott D
    Value Health Reg Issues; 2022 Jul; 30():140-147. PubMed ID: 35429927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The health gap and HRQoL inequalities in Greece before and during the economic crisis.
    Yfantopoulos J; Chantzaras A; Yfantopoulos P
    Front Public Health; 2023; 11():1138982. PubMed ID: 37342272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing the measurement equivalence of EQ-5D-5L across different modes of administration.
    Mulhern B; O'Gorman H; Rotherham N; Brazier J
    Health Qual Life Outcomes; 2015 Nov; 13():191. PubMed ID: 26612336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploratory Study of Dimensions of Health-related Quality of Life in the General Population of South Korea.
    Kim SH; Jo MW; Ock M; Lee SI
    J Prev Med Public Health; 2017 Nov; 50(6):361-368. PubMed ID: 29207449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Healthcare consumer acceptability of routine use of the EQ-5D-5L in clinical care: a cross-sectional survey.
    Snowdon DA; Collyer TA; Marsh L; Srikanth V; Beare R; Baber S; Naude K; Andrew NE
    Qual Life Res; 2024 May; 33(5):1307-1321. PubMed ID: 38321194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-Cultural Adaptation of the Beta EQ-5D-Y-5L Into Chichewa (Malawi).
    Ngwira LG; Jelsma J; Maheswaran H; Kapakasa F; Derrett S; Petrou S; Niessen L; Smith SC
    Value Health Reg Issues; 2022 May; 29():36-44. PubMed ID: 34801884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.
    Ferreira PL; Antunes P; Ferreira LN; Pereira LN; Ramos-Goñi JM
    Qual Life Res; 2019 Dec; 28(12):3163-3175. PubMed ID: 31201730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EQ-5D-5L Slovenian population norms.
    Prevolnik Rupel V; Ogorevc M
    Health Qual Life Outcomes; 2020 Oct; 18(1):333. PubMed ID: 33028345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychometric Properties of the Spanish Versions of EQ-5D-Y-3L and EQ-5D-Y-5L in Children with Cancer: A Comparative Study.
    Perez-Sousa MA; Olivares PR; Gusi N
    Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36141694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of EQ-5D-5L, VAS, and SF-6D in Thai Patients on Peritoneal Dialysis.
    Thaweethamcharoen T; Noparatayaporn P; Sritippayawan S; Aiyasanon N
    Value Health Reg Issues; 2019 May; 18():59-64. PubMed ID: 30502661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health-related quality of life measured with the EQ-5D-5L: estimation of normative index values based on a representative German population sample and value set.
    Grochtdreis T; Dams J; König HH; Konnopka A
    Eur J Health Econ; 2019 Aug; 20(6):933-944. PubMed ID: 31030292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A New Approach to Assessing Children's Interpretation of Severity Qualifiers in a Multi-Attribute Utility Instrument-The EQ-5D-Y-5L: Development and Testing.
    Derrett S; Herdman M; Ngwira LG; Moore EY; Jelsma J
    Patient; 2021 Sep; 14(5):591-600. PubMed ID: 33650034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.